Literature DB >> 20688912

Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.

Weimin C Hong1, Susan G Amara.   

Abstract

Clearance of synaptically released dopamine is regulated by the plasmalemmal dopamine transporter (DAT), an integral membrane protein that resides within a complex lipid milieu. Here we demonstrate that cholesterol, a major component of the lipid bilayer, can modulate the conformation of DAT and alter cocaine binding to DAT. In striatal synaptosomes and transfected cells, DAT was in cholesterol-rich membrane fractions after mild detergent extraction. After increasing the membrane cholesterol content by treatment of water-soluble cholesterol (cholesterol mixed with methyl-β-cyclodextrin), we observed an increase in DAT binding B(max) values for cocaine analogs [(3)H]WIN35428 and [(125)I]RTI-55, but similar levels of DAT proteins on the cell surface were shown by surface biotinylation assays. Membrane cholesterol addition also markedly enhanced the accessibility of cysteine sulfhydryl moieties in DAT as probed by a membrane-impermeable maleimide-biotin conjugate. We identified cysteine 306, a juxtamembrane residue on transmembrane domain 6 (TM6) of DAT, as the intrinsic residue exhibiting enhanced reactivity. Similar effects on DAT cysteine accessibility and radioligand binding were observed with addition of zinc, a reagent known to promote the outward facing conformation of DAT. Using substituted cysteine mutants on various positions likely to be extracellular, we identified additional residues located on TM1, TM6, TM7, and TM12 of DAT that are sensitive to alterations in the membrane cholesterol content. Our findings in transfected cells and native tissues support the hypothesis that DAT adopts an outward facing conformation in a cholesterol-rich membrane environment, suggesting a novel modulatory role of the surrounding membrane lipid milieu on DAT function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688912      PMCID: PMC2952264          DOI: 10.1074/jbc.M110.150565

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter.

Authors:  S L Ingram; S G Amara
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  Activity-dependent regulation of the dopamine transporter is mediated by Ca(2+)/calmodulin-dependent protein kinase signaling.

Authors:  Shalini Padmanabhan; Nevin A Lambert; Balakrishna M Prasad
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

3.  The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.

Authors:  M E Reith; J L Berfield; L C Wang; J V Ferrer; J A Javitch
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

4.  SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis.

Authors:  T Lang; D Bruns; D Wenzel; D Riedel; P Holroyd; C Thiele; R Jahn
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

5.  A competitive inhibitor traps LeuT in an open-to-out conformation.

Authors:  Satinder K Singh; Chayne L Piscitelli; Atsuko Yamashita; Eric Gouaux
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

6.  The substrates of the gamma-aminobutyric acid transporter GAT-1 induce structural rearrangements around the interface of transmembrane domains 1 and 6.

Authors:  Alex Rosenberg; Baruch I Kanner
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

7.  Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters.

Authors:  Ying-Jian Liang; Juan Zhen; Nianhang Chen; Maarten E A Reith
Journal:  J Neurochem       Date:  2009-03-11       Impact factor: 5.372

8.  Embedded cholesterol in the nicotinic acetylcholine receptor.

Authors:  Grace Brannigan; Jérôme Hénin; Richard Law; Roderic Eckenhoff; Michael L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

9.  The neuronal glycine transporter GLYT2 associates with membrane rafts: functional modulation by lipid environment.

Authors:  Enrique Núñez; Pablo Alonso-Torres; Amparo Fornés; Carmen Aragón; Beatriz López-Corcuera
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

10.  Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol.

Authors:  James D Foster; Steven D Adkins; John R Lever; Roxanne A Vaughan
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

View more
  77 in total

1.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

2.  Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113.

Authors:  Erik R Hill; Xiaoqin Huang; Chang-Guo Zhan; F Ivy Carroll; Howard H Gu
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

3.  Dopamine transporter is enriched in filopodia and induces filopodia formation.

Authors:  John Caltagarone; Shiqi Ma; Alexander Sorkin
Journal:  Mol Cell Neurosci       Date:  2015-04-30       Impact factor: 4.314

Review 4.  Alternating access mechanisms of LeuT-fold transporters: trailblazing towards the promised energy landscapes.

Authors:  Kelli Kazmier; Derek P Claxton; Hassane S Mchaourab
Journal:  Curr Opin Struct Biol       Date:  2016-12-30       Impact factor: 6.809

5.  Thermal Stability of Dopamine Transporters.

Authors:  Siim Kukk; Vladimir Stepanov; Jaak Järv
Journal:  J Membr Biol       Date:  2015-03-27       Impact factor: 1.843

6.  Neurotransmitter and psychostimulant recognition by the dopamine transporter.

Authors:  Kevin H Wang; Aravind Penmatsa; Eric Gouaux
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

7.  Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.

Authors:  Freja Herborg; Thorvald F Andreassen; Frida Berlin; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

Review 8.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

9.  Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.

Authors:  Weimin C Hong; Susan G Amara
Journal:  FASEB J       Date:  2013-04-23       Impact factor: 5.191

Review 10.  A role for sigma receptors in stimulant self-administration and addiction.

Authors:  Jonathan L Katz; Weimin C Hong; Takato Hiranita; Tsung-Ping Su
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.